Neuralstem to Present at The Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology

GERMANTOWN, Md., Jan. 5 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced Karl Johe, Ph.D, chief science officer Neuralstem, will present at the Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology at the Marines’ Memorial Club in San Francisco, CA. The presentation is scheduled [...]